Refine this list:
Priorclave set to target North American lab market – 16-May-2013
New steam steriliser production line will spearhead push into US
To provide a comprehensive service to VPHP technology users in the pharma and healthcare industry
Only dual-layered sterilisation wrap in US market cleared for current ASP Sterrad Systems modalities
Empowering the regulatory affairs professional– 8-Apr-2013
High Edge Consulting launches six new training courses in 2013
North America is largest regional market, with Asia the growing fastest
Capable of up to 6 logs surface sterilisation
Since 1988 Priorclave has delivered nearly 5,000 steam sterilisers worldwide
Comprises a vertical column housing a drive rack
Asian market will help drive growth owing to awareness of benefits
Johns Hopkins to begin decontaminating isolation rooms with Bioquell robotic devices
Japan’s Azbil takes 80% stake in Telstar– 4-Dec-2012
Telstar will lead the launch of a new business called Life Science Engineering
By using the DataTrace wireless data loggers
Sterilisation with steam– 29-Aug-2012
Steam sterilisation is still a popular choice for the medical device industry because it is very effective and relatively cheap and quick. To maintain sterility, the devices require packaging that acts as a sterile barrier after the sterilisation process. This means that the cycle has to be suitable, not only for the devices, but also for the associated packaging. Cycle development starts in the design phase with the choice of the materials of construction and packaging.
Isolator decontamination with nitrogen dioxide– 29-Aug-2012
The majority of isolators are decontaminated using hydrogen peroxide vapour technologies, but limitations in process control, aeration efficiency, and product compatibility have led to research into new decontamination methods. DNA in mammalian cells is degraded via single-strand breaks upon exposure to nitrogen dioxide, which is now being developed as a sterilant.
In-line sterilisation with pulsed light– 1-Aug-2012
The effectiveness of pulsed light in killing micro-organisms is well know, but until now there was no suitable testing environment that was sustainable and met industry standards. Claranor has developed a pulsed light sterilisation treatment that is reproducible and traceable. Each product receives exactly the same amount of energy, and the procedure is monitored and can be checked at any time
The pre-sterilisation paradox– 26-Mar-2012
Apart from the legal need to comply with the regulatory requirements governing sterile manufacturing of medical devices, manufacturers need to appreciate the inactivation kinetics of sterilisation technologies. They must also understand the types of viable and non-viable contamination and their effects on the human body. Manufacturers are advised to determine their cleanliness requirements as a result of a formal risk analysis exercise. A review and assessment of control plans with microbiologist support is strongly encouraged.
Harnessing UVC light– 23-Jan-2012
Ultraviolet light offers an energy- and cost-efficient method of decontaminating medical and electronic devices. When targeted micro-organisms are directly exposed to UVC light, the radiation penetrates the cell walls. UVC exposure in the Nanoclave Cabinet occurs at room temperature and pressure and doesn’t involve moisture or immersion.
Applied Sterilisation– 29-Oct-2012
5 - 7 November 2013
Three-day training course
Barnard Castle, UK
Pharmaceutical Sterilisation: Principles in Practice– 29-Oct-2012
10 - 12 September 2013
Barnard Castle, UK